FDA rejection
-
antidepressants, depression, Drugs, FDA rejection, functional unblinding, Lykos, mdma, media coverage, neuroscience, psilocybin, psychedelic medicine, Psychiatry, Psychology, PTSD, science communication, Stress, treatment-resistant depressionPsychedelic Media Coverage Outpaced Evidence (2017–2024)
Psychedelic-assisted therapy has been one of the most-covered mental-health stories of the…
